LEADER 03726nam  22005652  450 
001 9910956993003321
005 20251114022137.0
010   $a9789815011425
010   $a9815011421
024 7 $a10.1355/9789815011425
035   $a(MiAaPQ)EBC6893958
035   $a(Au-PeEL)EBL6893958
035   $a(CKB)21325726900041
035   $a(OCoLC)1299382353
035   $a(MdBmJHUP)musev2_101462
035   $a(DE-B1597)652371
035   $a(DE-B1597)9789815011425
035   $a(UkCbUP)CR9789815011425
035   $a(Perlego)4196096
035   $a(UkCbUP)CR9789815011418
035   $a(EXLCZ)9921325726900041
100   $a20230804d2023||||  uy|         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$a'Building a Sailboat in a Storm' $eThe Evolution of COVAX in 2021 and its Impact on Supplies to Southeast Asia's Six Lower-Income Economies /$fKhairulanwar  Zaini
205   $aFirst edition.
210  1$aSingapore :$cISEAS?Yusof Ishak Institute,$d2023.
215   $a1 online resource $cdigital, PDF file(s)
225 1 $aTrends in Southeast Asia ;$vissue 4, 2022
300   $aTitle from publisher's bibliographic system (viewed on 14 Nov 2025).
311 08$a9789815011418 
311 08$a9815011413 
327   $tFrontmatter -- $tFOREWORD -- $tEXECUTIVE SUMMARY -- $tINTRODUCTION -- $tHOW THE ?BEAUTIFUL IDEA? OF COVAX FALTERED -- $tCOVAX?S FIRST PHASE: AN ?ABYSMAL FAILURE? FOR THE AMC6 IN 1H 2021 -- $tCOVAX?S SECOND PHASE: THE PIVOT TO DOSE DONATIONS -- $tTHE AMC6?S BURGEONING COVAX SUPPLY IN 2H -- $tW(H)ITHER COVAX 2.0? -- $tCOVAX 2.0: A BOON WITH HIDDEN COSTS AND CONSEQUENCES?
330   $aIn the first half of 2021, COVID-19 vaccine doses from the COVAX Facility were in short supply, and the plan to mass produce COVAX vaccines through the Serum Institute of India (SII) faltered as the pandemic surged in India in March 2021. Due to COVAX's shift in approach towards convincing richer nations to redistribute their excess doses, the second half of 2021 saw increases in the frequency and volume of its shipments. Donors were however able to 'earmark' their dose donations and identify their intended recipients. The six Southeast Asian countries which qualified for free COVAX shots - Cambodia, Indonesia, Laos, the Philippines, Timor-Leste and Vietnam (the AMC6) - received 16 million doses in the first half of 2021. In the second half, they received 128 million doses from COVAX, 80.9 per cent of which were earmarked donations. Despite making up 7 per cent of the world population, the AMC6 collectively accounted for 24.3 per cent of all earmarked dose donations (and 25 per cent of the United States' total dose donations) to COVAX in 2021. The AMC6 greatly benefitted from COVAX's pivot to dose donations. This demonstrated the region's strategic salience to Washington and its allies, but came at the expense of vaccine equity, which the region has prudential reasons to care about. The execution of COVAX hammers home the hard truth that multilateral governance is a difficult act to pull off even with the best intentions and is not impervious to the geopolitical interests and agendas of the major powers.
410  0$aTrends in Southeast Asia ;$vissue 4, 2022.
606   $aDrug accessibility$zSoutheast Asia
606   $aDrug accessibility
615  0$aDrug accessibility
615  0$aDrug accessibility.
676   $a362.1969792
700   $aKhairulanwar Zaini$01861384
801  0$bUkCbUP
801  1$bUkCbUP
906   $aBOOK
912   $a9910956993003321
996   $aBuilding a Sailboat in a Storm$94467467
997   $aUNINA